MAPT and Alzheimer disease: To minimize variability during the compound screening endeavor, three separate preparations of AD-tau were generated from autopsied human brain with a neuropathological diagnosis of advanced AD (Braak stage 6), with representative immunohistochemical images of the extent of PHF1-positive tau pathology for each case depicted in Fig. S1A.